Are sTWEAK and IL-17A Levels in Inflammatory Bowel Disease Associated with Disease Activity and Etiopathogenesis? (original) (raw)

Increased expression of interleukin 17 in inflammatory bowel disease

Yoshihiko Araki

Gut, 2003

View PDFchevron_right

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD

Matthias Jürgens

Inflammatory Bowel Diseases, 2008

View PDFchevron_right

Roles of IL-17A and IL-23 in the Pathogenesis of Ulcerative Colitis and Crohn’s Disease

dr.ekhlass ali

Iraqi Journal of Science

View PDFchevron_right

" Tissue IL-17A expression associated with inflammatory lesions and ATG16L1 T300A allele in Crohn's disease "

Nidhal A. A Mohammed

View PDFchevron_right

Differential Regulation of INTERLEUKIN-17 and Interferon-Gamma Production in Inflammatory Bowel Disease

David Rampton

Digestive and Liver Disease, 2009

View PDFchevron_right

Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease

Maria Ioana Ilies

Journal of Personalized Medicine, 2021

View PDFchevron_right

Serum IL-17A in Newly Diagnosed Treatment-Naive Patients with Ulcerative Colitis Reflects Clinical Disease Severity and Predicts the Course of Disease

Magnus Simrén

Inflammatory Bowel Diseases, 2013

View PDFchevron_right

Faculty of 1000 evaluation for Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases

David Goldsmith

F1000 - Post-publication peer review of the biomedical literature, 2011

View PDFchevron_right

Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis

Izet Hozo

Hepato-gastroenterology

View PDFchevron_right

Serum Interleukin 17 Levels in Patients with Crohn’s Disease: Real Life Data

Kamil Ozdil

Disease Markers, 2014

View PDFchevron_right

Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients

Heena Mehta

Frontiers in Immunology, 2019

View PDFchevron_right

Interleukin-17 Serum Levels and TLR4 Polymorphisms in Ulcerative Colitis

Mojgan Mohammadi

View PDFchevron_right

Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease

Ioana Berindan Neagoe

World journal of gastroenterology : WJG, 2015

View PDFchevron_right

IL-23/IL-17 immunity as a hallmark of Crohnʼs disease

Kaija-leena Kolho

Inflammatory Bowel Diseases, 2008

View PDFchevron_right

Tumor necrosis factor-alpha serum level in assessment of disease activity in inflammatory bowel diseases

Nermina Babic

PubMed, 2013

View PDFchevron_right

Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice

Yoichiro Iwakura

Biochemical and Biophysical Research Communications, 2008

View PDFchevron_right

Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease

Bent Deleuran

Journal of Crohn's and Colitis, 2013

View PDFchevron_right

IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid

MOURAD BELKHELFA

Journal of Interferon & Cytokine Research, 2013

View PDFchevron_right

Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician

Guoqing Hou

Inflammatory Bowel Diseases, 2020

View PDFchevron_right

The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis

Sandro Ardizzone

Fibrogenesis & Tissue Repair, 2013

View PDFchevron_right

Expression of IL-2, IL-17 and TNF-alpha in patients with Crohn's disease treated with anti-TNF antibodies

Uri Kopylov

Clinics and Research in Hepatology and Gastroenterology, 2014

View PDFchevron_right

Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases

Baatarsuren Batmunkh

Acta Histochemica et Cytochemica

View PDFchevron_right

Tumor Necrosis Factor-α in Serum of Patients with Inflammatory Bowel Disease as Measured by a Highly Sensitive Immuno-PCR

Momoko Komatsu

Clinical Chemistry, 2001

View PDFchevron_right

Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth

Stanley Schwartz

Biochemical and Biophysical Research Communications, 2005

View PDFchevron_right

Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease

Ilona Kryczek

Journal of Translational Medicine, 2011

View PDFchevron_right

CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease

Glen Doherty, Garrett Lawlor

European Journal of Immunology, 2012

View PDFchevron_right

Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages

Hermann Kessler

Gastroenterology, 2011

View PDFchevron_right

Molecular analyses of ADAMTS-1, -4, -5, and IL-17 a cytokine relationship in patients with ulcerative colitis

Tahir Buran

BMC Gastroenterology

View PDFchevron_right

The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease

Mahmut Yüksel

Medicine, 2016

View PDFchevron_right

Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease

Sarah Thunberg

Clinical & Experimental Immunology, 2012

View PDFchevron_right

Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models

D. Bullens

Clinical and Experimental Immunology, 2004

View PDFchevron_right

New concepts in the pathophysiology of inflammatory bowel disease

Giorgos Bamias, S. De La Rue

Annals of internal medicine, 2005

View PDFchevron_right

In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells

Erkki Savilahti

ISRN gastroenterology, 2012

View PDFchevron_right

Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease

Marc Ferrante

Expert Opinion on Biological Therapy, 2016

View PDFchevron_right